Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine

BACKGROUND: Tamoxifen is one of the medicines for adjuvant endocrine therapy of hormone-dependent breast cancer. However, development of resistance to tamoxifen occurs inevitably during treatment. This study aimed to determine whether sensitivity of tamoxifen-resistant breast cancer cells (TAM-R) co...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuntao, Yue, Wei, Lang, Haiyan, Ding, Xiaoqing, Chen, Xinyi, Chen, Haiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164553/
https://www.ncbi.nlm.nih.gov/pubmed/33660534
http://dx.doi.org/10.1177/1534735421996822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164553/
https://www.ncbi.nlm.nih.gov/pubmed/33660534
http://dx.doi.org/10.1177/1534735421996822

Ejemplares similares